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Medical data bases have become an increasingly popular 
tool in clinical research. The observational data can be used 
to generate hypotheses for the development of clinical 
prediction rules and confirmation or extension of findings 
from other studies. When the analyses are carefully per- 
formed, the results from observational data bases generally 
have confirmed and complemented the findings of major 
randomized trials. In recent years, important clinical in- 
sights have been derived from analyses of data bases of 
large scale epidemiologic investigations; such insights may 
provide significant information on the impact of health 
policy decisions on patient care. To maximally and care- 
fully use observational data, certain principles in both 
study design and the data collection and analysis phases 
should be applied. 
(,I Am Co11 Cardiol1989;14:44A-7A) 
Role of Medical Data Bases in 
Clinical Research 
Although randomized trials are accepted as the ideal 
methodology for evaluating a therapy, there are many clin- 
ical issues for which this experimental study design is 
inappropriate or impractical (1). For example, randomized 
trials are generally not useful for the identification of risk 
factors for adverse outcomes. When the goal of the investi- 
gation is the evaluation of an intervention, randomized trials 
may be impossible when the disease of interest is rare (for 
example, congenital heart diseases) or the outcome of inter- 
est occurs at a low rate because of statistical power limita- 
tions. Furthermore, even when a randomized trial has been 
performed, it may not resolve management issues for impor- 
tant subgroups of the study patients or other groups that may 
have been excluded from the study, such as the elderly, 
women or patients with a low ejection fraction. 
Types of medical data bases. As a result, medical data 
bases have become an increasingly popular tool in clinical 
research (2). The observational data that are collected within 
these data bases have been used for exploratory (hypothesis- 
generating) analyses, the development of clinical prediction 
rules (3) and the confirmation or extension of findings from 
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other studies (4). When analyses are carefully performed, 
the results generally have confirmed and complemented the 
findings of major randomized trials (4). 
Several different types of data bases are currently being 
used in clinical investigations. The most common is the 
limited data base that is compiled for a single investigation, 
often by a single investigator. In contrast, many investiga- 
tors are needed to start or maintain larger data bases such as 
the Duke University Cardiovascular Disease Databank (5) or 
the National Heart, Lung, and Blood Institute Percutaneous 
Transluminal Coronary Angioplasty Registry (6), which 
have been developed to capture the clinical experience with 
one set of diseases or a new technology over several years. 
These larger data bases can provide data for many investi- 
gations over a long period. Data that have been collected in 
the course of a randomized trial such as the Coronary Artery 
Surgery Study (CASS) Registry (7) can also be used for 
analyses that are only indirectly related to the original 
investigation. 
In recent years, many investigators have taken advantage 
of data bases that have been compiled for purposes other 
than hospital-based research. For example, important clini- 
cal insights have been derived from analysis of the data 
bases of large-scale epidemiologic investigations such as the 
Framingham Heart Study (8) or the Nurses’ Health Study 
(9). Similarly, health care researchers are using nonmedical 
data bases such as hospital fiscal or Medicare/Medicaid data 
bases, and analyzing these data separately or using them to 
complement independently collected clinical data. These 
studies may provide clinical findings or insights into the 
impact of health policy measures on patient care (10). 
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Principles of data base collection and analysis. Regardless 
of the type of data base, there are potential liabilities that 
must be considered when using observational data. These 
liabilities are magnified if the investigator was not involved 
in the data-gathering process because he or she may not be 
aware of which variables are unreliable. Furthermore, in the 
analysis of observational data, the relation between an 
exposure (for example, cardiac surgery) and an outcome (for 
example, death) is likely to be confounded by differences in 
the distribution of clinical characteristics between exposed 
and unexposed subjects. 
To minimize these liabilities, investigators should apply 
certain principles in both the study design and data collec- 
tion and analysis phases of an investigation. The underlying 
themes to these principles are: I) ensuring that data are 
collected as objectively as possible, and 2) ensuring that 
comparisons are made between groups that are truly com- 
parable. Some of these principles will be outlined in the 
following discussion. 
Study Design and Data Collection 
Prospective data collection. Studies that use observa- 
tional data are often incorrectly perceived as retrospective 
by their very nature and, hence, susceptible to bias. In 
actuality, many observational data bases collect data pro- 
spectively; even data that are retrieved from a review of 
medical records may be recorded prospectively if the inves- 
tigator uses an appropriate study design. Thus, if clinical 
information was entered into the medical record by a physi- 
cian who did not know the patient’s outcome, and if that 
information is recorded from the chart by a researcher who 
also did not know the patient’s outcome status or the study 
hypothesis, the introduction of bias can be avoided. 
The collection of prospective data on large numbers of 
patients can often be integrated into routine patient care. For 
example, in the Multicenter Chest Pain Study (I I-141, we 
studied the ability of data from the emergency department 
evaluation of patients with acute chest pain to predict acute 
myocardial infarction and complications of ischemic heart 
disease that require intensive care unit management. In the 
collection of emergency department clinical data on approx- 
imately 15,000 patients at seven different hospitals, it was 
essential that the information be recorded without knowl- 
edge of the patient’s actual outcome or diagnosis. If an 
investigator knows that a patient had had an acute myocar- 
dial infarction, he or she might be more likely to interpret an 
equivocal electrocardiogram as showing evidence of isch- 
emia. The result of such a subtle bias might be an overesti- 
mation of the predictive value of the electrocardiogram. 
Therefore, we sought the cooperation of the physicians in 
the emergency departments and the medical records depart- 
ments at these hospitals, and arranged for a standardized 
study data form to be used as the official emergency depart- 
ment note. Instead of writing a text note on the blank sheet 
that usually serves as the emergency room form, the evalu- 
ating physicians entered clinical data on the study data form. 
which was placed in the medical record and substituted for 
the usual text. A copy of the form was also taken by the 
Chest Pain Study research assistants and used for data entry. 
Patients were classified on the occurrence of outcome 
events such as a diagnosis of acute myocardial infarction on 
the basis of subsequent cardiac enzyme results and clinical 
events. In cases when the outcome was uncertain, other 
reviewers who did not know the emergency department data 
were asked to classify the patient. 
With this study design, the clinical data could not be 
biased by knowledge of the patient’s outcome, and the 
definition of outcomes could not be biased by knowledge of 
the clinical data. 
This approach demonstrates the advantages of integrating 
data collection into routine care in large-scale studies. It 
would have been both expensive and impractical to have 
research assistants record emergency department clinical 
data from chart reviews or interviews, and it would probably 
have been impossible to ensure that the data were recorded 
without knowledge of patient outcome. The emergency 
department physicians benefited by having a convenient 
alternative to writing a full text note, and the Chest Pain 
Study was able to collect unbiased data at low costs. 
Although cost may not be an issue in investigations involving 
smaller numbers of patients, controlling potential bias is 
essential regardless of the size of the data base. 
Objective, reproducible data recording. Even if data are 
collected prospectively, they may lose their value if they are 
not recorded in an objective and reproducible manner. 
Nonrandom error will occur if data are recorded differently 
for patients with various outcomes. For example, an inves- 
tigator might be more likely to perceive ischemic changes on 
the electrocardiogram of patients who were known to have 
died, and thus distort the predictive value of such changes. 
In such situations, specific bias will be introduced. 
Random error is introduced if a variable is recorded with 
a high degree of variability in all patient groups. In this 
situation, a true relation between that variable and the 
outcome might be overlooked; thus, the study would be 
biased toward the null hypothesis. 
Clear definitions of variables and outcomes of interest. 
Investigators who have the opportunity to design their own 
data sets should, therefore, establish clear definitions of the 
variables and outcomes of interest. These definitions should 
be available in writing during data collection and analysis, 
and any changes or additions to the “code book” should be 
documented. A code book is essential if multiple reviewers 
perform the data collection, and useful even if only one 
person is involved. 
With these definitions, multiple reviewers should be able 
to place patients in mutually exclusive categories reproduc- 
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ibly. These categories should reflect important clinical dis- 
tinctions. For example, patients should not be classified 
simply as smokers or nonsmokers; multiple specific catego- 
ries are needed to capture information on how much they 
smoke, how long they have smoked or how much time has 
passed since they have quit. Areas of potential uncertainty 
can often only be detected with pilot testing of a data form. 
When investigators are working with data sets that have 
been collected by others, they should be sure that they know 
the precise definitions of variables. There is no substitute for 
collaboration with someone who was involved in the data 
collection because that person is most likely to know how 
questions were asked and which variables are unreliable. 
Investigators who use data bases that have been gathered 
for purposes other than medical research, such as fiscal data 
bases, should also be aware that the accuracy of such data 
may not meet usual research standards. As an example, 
Iezzoni et al. (15) recently reported that 260 (26%) of 1,003 
cases that had been coded as acute myocardial infarction by 
the medical records departments at 15 Boston hospitals did 
not meet clinical criteria for this diagnosis. Error rates in this 
range can be expected for other variables in nonresearch 
data bases. As just noted, if these errors are random, the 
analysis will be biased toward the null hypothesis; if they are 
nonrandom, a specific bias will be introduced. 
Analysis 
Avoiding adjusting for confounding factors. In analyzing 
observational data, investigators must always be concerned 
that an apparent association between a factor of interest 
(that is, the exposure) and outcome may result from con- 
founding by a third factor that is associated with both the 
exposure and the outcome. For example, the observation 
that the mortality rate is higher among patients who are 
treated with digoxin after acute myocardial infarction than 
among patients who do not receive this medication (16) did 
not appear to be a function of deleterious effects of digoxin, 
but rather was reflective of greater severity of illness among 
the patients who received digoxin. 
Several strategies may be employed to adjust for the 
potential impact of such confounding differences, but funda- 
mental to all strategies is that the investigator cannot detect 
confounding if he or she does not look for it. Thus, investi- 
gators should collect and include in their analysis data on all 
variables that are potential confounders. 
The simplest and most intuitive strategy for avoiding 
confounding is to match patients on the basis of potential 
confounding characteristics. Thus, to compare the rates of 
coronary artery disease in patients who do and do not drink 
alcohol, one could match patients in the two groups on the 
basis of factors that were risk factors for coronary heart 
disease, such as smoking status. This strategy would ensure 
that the role of smoking was the same in both the drinking 
and nondrinking groups and, therefore, remove its effect 
from the analysis. 
The disadvantage of this approach is that the matching 
process becomes unwieldy when there are many potential 
confounders. In the preceding example, to control for con- 
founding by other risk factors for coronary heart disease, 
patients would have to be matched not only for smoking 
status, but also for age, blood pressure, cholesterol levels, 
diabetes status, weight and family history. 
Similarly, stratified analyses that divide patients into 
strata defined by potential confounders are simple and 
intuitive, but also suffer from the disadvantage of being 
impractical when there are many potential confounders. For 
example, if one creates a stratum for diabetic smokers, strata 
must also be created for diabetic nonsmokers, nondiabetic 
smokers and nondiabetic nonsmokers. Consideration of 
other confounders would lead to an exponential increase in 
the number of strata; hence, many strata would not have 
enough subjects in them for efficient or meaningful analysis. 
Multivariate and parametric analysis. These limitations 
help explain the growing popularity of sophisticated multi- 
variate techniques that are now widely available in software 
packages for microcomputers and minicomputers. For anal- 
yses with dichotomous end points (for example, dead or 
alive), parametric techniques such as multiple logistic re- 
gression (17,18) or linear discriminant analysis (19) can be 
used to identify the independent predictive importance of the 
exposure of interest and the potential confounders. 
Although these techniques are powerful, they should be 
used only by investigators who are aware of the assumptions 
on which they are based. For example, with logistic regres- 
sion analysis, interactions between covariates may not be 
detected if they are not anticipated in advance. Limitations 
of parametric techniques have led to interest in nonparamet- 
ric multivariate techniques such as recursive partitioning 
(20). The relative merits of these approaches have been 
discussed elsewhere (21). 
Another approach attempts to combine the features of 
cross-stratification and multivariate modeling by stratifying 
subjects according to their values from a model known 
variously as a “multivariate confounder score” (22) or a 
“propensity score” (23). A multivariate confounder score, 
as proposed by Miettinen (22), is derived by developing 
either an outcome model for the risk of the outcome as a 
function of the possible confounders and the exposure or, 
alternatively, an exposure model that describes the preva- 
lence of the exposure in the study population as a function of 
the possible confounders and the outcome. In either case, 
the subjects are then stratified on the basis of their “score” 
according to the model; then, the association of the exposure 
and outcome is evaluated across these strata. 
The propensity score. This score, as proposed by Rosen- 
baum and Rubin (23) for cohort studies, is developed from an 
exposure model and differs from the multivariate confounder 
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score by not containing a term for the outcome. Rosenbaum 
and Rubin (23) demonstrated that not including a term for the 
outcome is appropriate for cohort studies, and described 
how this approach might be preferable when more than one 
outcome is under consideration and when the outcome is 
ordinal or continuous in scale. 
This approach has been used. for example. to clarify the 
relation between the use of digoxin and death after acute 
myocardial infarction (16). Nevertheless, the complexity of 
these combination methods has restricted their application in 
clinical investigation despite their intuitive appeal. Further- 
more, the resulting strata, which are based on a “score” 
from a multivariate model, may possess little intrinsic mean- 
ing beyond representing different levels of risk or exposure 
prevalence. Ti, address these problems, Cook and Goldman 
(24) recently described asymmetric stratification. a tech- 
nique that uses recursive partitioning instead of a propensity 
score to develop strata to control for the relations between 
potential confounders and either the exposure or outcome of 
interest. 
Conclusions. Regardless of the analytic strategy, one can 
never be sure that all potential confounders have been 
recognized. There may be unknown risk factors for an 
outcome that are distributed unevenly in the study popula- 
tion. As a result, analysis of observational data can never 
prove causation beyond a shadow of a doubt. However, 
reproducible, strong associations that demonstrate a dose- 
response effect may be sufficient to guide clinical practice or 
identify issues that are appropriate for randomized trials. 
In this age of cost constraints on research of all types, the 
role of data base research in clinical investigation can be 
expected to expand. As this expansion occurs, methodologic 
standards for the development and analysis of observational 
data bases should become better defined and accepted. 
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